Pros | ![]() Lower expense ratio. ![]() Beats FD returns for both 3Y & 5Y duration. | |||
Cons | - |
INDMoney rank | 5/8 | |||
Category,Subcateogry | Equity,Sector - Healthcare | |||
Fund Age | 6 Years | |||
Fund Size | 2441 Cr | |||
Min Investment | SIP ₹99 Lumpsum ₹5000 | |||
Expense Ratio | 0.52% | |||
Exit Load | 1% | |||
Benchmark Index | S&P BSE Healthcare PR |
No of Holdings | 34 | |||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.84%) Cipla Ltd (7.6%) Aurobindo Pharma Ltd (7.09%) Divi's Laboratories Ltd (6.53%) Lupin Ltd (6.36%) | |||
No of Sectors | 3 | |||
Top 3 Sectors | Health (98.63%) Basic Materials (0.86%) Industrial (0.51%) | |||
Equity % | 99.6% | |||
Debt % | - | |||
P/E | 33.85 | |||
P/B | 4.98 | |||
Credit Quality | - | |||
Modified Duration | - | |||
YTM | - |
1-Month Return | 9.16% | |||
3-Month Return | -6.02% | |||
6-Month Return | -6.42% | |||
1-Year Return | 18.97% | |||
3-Year Return | 19.77% | |||
5-Year Return | 30.98% |
Sharpe | 0.69 | |||
Alpha | -0.39 | |||
Beta | 0.97 | |||
Standard Deviation | 16.65 | |||
Information Ratio | -0.26 |
Description | Mirae Asset Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | |||
Managers | Vrijesh Kasera |